Drugs Controller General of India (DCGI) has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate...
https://ift.tt/eA8V8J
from NDTV News - Topstories https://ift.tt/2Fksy5W
https://ift.tt/eA8V8J
from NDTV News - Topstories https://ift.tt/2Fksy5W
Comments
Post a Comment